These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 16391183)
1. Comparison of 2-dimensional and 3-dimensional acquisition for 18F-FDG PET oncology studies performed on an LSO-based scanner. Lodge MA; Badawi RD; Gilbert R; Dibos PE; Line BR J Nucl Med; 2006 Jan; 47(1):23-31. PubMed ID: 16391183 [TBL] [Abstract][Full Text] [Related]
2. A lesion detection observer study comparing 2-dimensional versus fully 3-dimensional whole-body PET imaging protocols. Lartizien C; Kinahan PE; Comtat C J Nucl Med; 2004 Apr; 45(4):714-23. PubMed ID: 15073270 [TBL] [Abstract][Full Text] [Related]
3. Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera. Everaert H; Vanhove C; Lahoutte T; Muylle K; Caveliers V; Bossuyt A; Franken PR Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1615-9. PubMed ID: 14504831 [TBL] [Abstract][Full Text] [Related]
4. Impact of acquisition geometry, image processing, and patient size on lesion detection in whole-body 18F-FDG PET. El Fakhri G; Santos PA; Badawi RD; Holdsworth CH; Van Den Abbeele AD; Kijewski MF J Nucl Med; 2007 Dec; 48(12):1951-60. PubMed ID: 18006613 [TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of 2D versus 3D whole-body PET image quality using a dedicated BGO PET scanner. Visvikis D; Griffiths D; Costa DC; Bomanji J; Ell PJ Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1050-6. PubMed ID: 15846487 [TBL] [Abstract][Full Text] [Related]
6. Two-dimensional vs three-dimensional imaging in whole body oncologic PET/CT: a Discovery-STE phantom and patient study. Bettinardi V; Mancosu P; Danna M; Giovacchini G; Landoni C; Picchio M; Gilardi MC; Savi A; Castiglioni I; Lecchi M; Fazio F Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):214-23. PubMed ID: 17464266 [TBL] [Abstract][Full Text] [Related]
7. Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability. Halpern BS; Dahlbom M; Quon A; Schiepers C; Waldherr C; Silverman DH; Ratib O; Czernin J J Nucl Med; 2004 May; 45(5):797-801. PubMed ID: 15136629 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of optimized injection dose and acquisition time using body mass index for three-dimensional whole-body FDG-PET]. Matsumoto K; Matsuura H; Minota E; Sakamoto S; Nakamoto Y; Senda M Nihon Hoshasen Gijutsu Gakkai Zasshi; 2004 Nov; 60(11):1564-73. PubMed ID: 15568009 [TBL] [Abstract][Full Text] [Related]
10. Quantitative comparison of analytic and iterative reconstruction methods in 2- and 3-dimensional dynamic cardiac 18F-FDG PET. Lubberink M; Boellaard R; van der Weerdt AP; Visser FC; Lammertsma AA J Nucl Med; 2004 Dec; 45(12):2008-15. PubMed ID: 15585474 [TBL] [Abstract][Full Text] [Related]
11. Investigation of 18F-FDG 3D mode PET image quality versus acquisition time. Brown C; Dempsey MF; Gillen G; Elliott AT Nucl Med Commun; 2010 Mar; 31(3):254-9. PubMed ID: 20032801 [TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET for detecting myocardial viability: validation of 3D data acquisition. Brogsitter C; Grüning T; Weise R; Wielepp P; Lindner O; Körfer R; Burchert W J Nucl Med; 2005 Jan; 46(1):19-24. PubMed ID: 15632028 [TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of PET image reconstruction using a spatial resolution model. Andersen FL; Klausen TL; Loft A; Beyer T; Holm S Eur J Radiol; 2013 May; 82(5):862-9. PubMed ID: 23254158 [TBL] [Abstract][Full Text] [Related]
14. Lutetium oxyorthosilicate (LSO) intrinsic activity correction and minimal detectable target activity study for SPECT imaging with a LSO-based animal PET scanner. Yao R; Ma T; Shao Y Phys Med Biol; 2008 Aug; 53(16):4399-415. PubMed ID: 18670052 [TBL] [Abstract][Full Text] [Related]
15. Three-dimensional positron emission tomography imaging with 124I and 86Y. Vandenberghe S Nucl Med Commun; 2006 Mar; 27(3):237-45. PubMed ID: 16479243 [TBL] [Abstract][Full Text] [Related]
16. Performance characteristics of a newly developed PET/CT scanner using NEMA standards in 2D and 3D modes. Mawlawi O; Podoloff DA; Kohlmyer S; Williams JJ; Stearns CW; Culp RF; Macapinlac H; J Nucl Med; 2004 Oct; 45(10):1734-42. PubMed ID: 15471842 [TBL] [Abstract][Full Text] [Related]
17. Imaging of weak-source distributions in LSO-based small-animal PET scanners. Goertzen AL; Suk JY; Thompson CJ J Nucl Med; 2007 Oct; 48(10):1692-8. PubMed ID: 17873140 [TBL] [Abstract][Full Text] [Related]
18. Initial experience with a prototype dual-crystal (LSO/NaI) dual-head coincidence camera in oncology. Joshi U; Hoekstra OS; Boellaard R; Comans EF; Raijmakers PG; Pijpers RJ; Miller SD; Teule GJ; van Lingen A Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):596-8. PubMed ID: 14722683 [TBL] [Abstract][Full Text] [Related]